17 alpha-Hydroxyprogesterone Caproate FDA Link

Hydroxyprogesterone derivative that acts as a PROGESTIN and is used to reduce the risk of recurrent MISCARRIAGE and of PREMATURE BIRTH. It is also used in combination with ESTROGEN in the management of MENSTRUATION DISORDERS.

Also Known As:

Delalutin; 17 alpha-Oxyprogesterone Capronate; 17-Hydroxyprogesterone Capronate; 17-alpha-Hydroxy-Progesterone Caproate; Hydroxyprogesterone Caproate; Hydroxyprogesterone Hexanoate; Makena; Neolutin; Oxyprogesterone Caproate; Prolutin Depot; Proluton Depot; 17 Hydroxyprogesterone Capronate; 17 alpha Hydroxy Progesterone Caproate; 17 alpha Hydroxyprogesterone Caproate; 17 alpha Oxyprogesterone Capronate; Caproate, 17-alpha-Hydroxy-Progesterone; Hexanoic acid, 3,20-dioxopregn-4-en-17-yl ester

Polycyclic Compounds: 6
- Fused-Ring Compounds
  - Steroids: 70059
    - Pregnanes: 9
      - Pregnenes: 1
        Pregnenediones
        Progesterone: 12723
        Hydroxyprogesterones
        17-alpha-Hydroxyprogesterone: 804
        17 alpha-Hydroxyprogesterone Caproate: 173
Hormones, Hormone Substitutes, and Hormone Antagonists
- Hormones: 80400
  - Gonadal Hormones: 716
    - Gonadal Steroid Hormones: 7657
      - Progesterone Congeners: 320
        Progesterone: 12723
        Hydroxyprogesterones
        17-alpha-Hydroxyprogesterone: 804
        17 alpha-Hydroxyprogesterone Caproate: 173

W Andrews Selected Research

W Andrews Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure